RGT 3.45% 28.0¢ argent biopharma limited

"Based on the glioblastoma cells and stem cells response, the...

  1. 166 Posts.
    lightbulb Created with Sketch. 50
    "Based on the glioblastoma cells and stem cells response, the Company will start to design a clinical study in humans, to treat patients with the most effective combinations of cannabinoids to reduce tumour volume"

    Now able to be tested on humans, the results of this could be massive!

    GLTAH
    Last edited by alaedean: 29/07/19
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.